We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$5.45B
2
STI
SunTrust Banks, Inc.
STI
+$2.42B
3
VIAB
Viacom Inc. Class B
VIAB
+$967M
4
GPN icon
Global Payments
GPN
+$641M
5
GWR
Genesee & Wyoming Inc.
GWR
+$574M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMDX icon
2751
Transmedics
TMDX
$2.91B
$12.4M ﹤0.01%
654,280
+301,818
+86% +$5.54M
SRRK icon
2752
Scholar Rock
SRRK
$6.44B
$12.4M ﹤0.01%
942,554
-2,521
-0.3% -$24.2K
SYRS
2753
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$12.4M ﹤0.01%
179,710
+141
+0.1% +$8.55K
WNEB icon
2754
Western New England Bancorp
WNEB
$275M
$12.4M ﹤0.01%
1,284,995
-99,817
-7% -$965K
PLYM
2755
DELISTED
Plymouth Industrial REIT
PLYM
$12.4M ﹤0.01%
672,585
+57,300
+9% +$1.06M
LXRX icon
2756
Lexicon Pharmaceuticals
LXRX
$1.1B
$12.4M ﹤0.01%
2,976,003
-85,986
-3% -$331K
SOHU
2757
Sohu.com
SOHU
$357M
$12.3M ﹤0.01%
1,104,256
+6,394
+0.6% +$67K
MNOV icon
2758
MediciNova
MNOV
$66M
$12.3M ﹤0.01%
1,827,342
+113,309
+7% +$852K
APYX icon
2759
Apyx Medical
APYX
$171M
$12.3M ﹤0.01%
1,454,926
+30,666
+2% +$222K
PARAA
2760
DELISTED
Paramount Global Class A
PARAA
$12.3M ﹤0.01%
274,116
+235,964
+618% +$10M
TPB icon
2761
Turning Point Brands
TPB
$1.74B
$12.2M ﹤0.01%
427,548
+2,819
+0.7% +$70.7K
REV
2762
DELISTED
Revlon, Inc.
REV
$12.2M ﹤0.01%
570,083
+14,444
+3% +$348K
QTT
2763
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$12.2M ﹤0.01%
357,977
+27,042
+8% +$902K
CWBC
2764
Community West Bancshares
CWBC
$684M
$12.2M ﹤0.01%
561,389
-1,181
-0.2% -$24.7K
PRTA icon
2765
Prothena Corp
PRTA
$450M
$12.2M ﹤0.01%
768,497
-83,762
-10% -$898K
FARM
2766
DELISTED
Farmer Brothers
FARM
$12.2M ﹤0.01%
807,616
-5,478
-0.7% -$79.9K
MNKD icon
2767
MannKind Corp
MNKD
$1.32B
$12.2M ﹤0.01%
9,428,927
+271,320
+3% +$347K
FRTA
2768
DELISTED
Forterra, Inc
FRTA
$12.1M ﹤0.01%
1,046,708
+1,547
+0.1% +$15K
HBMD
2769
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$12.1M ﹤0.01%
715,183
+77,707
+12% +$1.29M
MTNB icon
2770
Matinas BioPharma
MTNB
$1.81M
$12.1M ﹤0.01%
106,176
+2,538
+2% +$147K
APRE icon
2771
Aprea Therapeutics
APRE
$8.05M
$12M ﹤0.01%
+13,100
New +$7.21M
CNBKA
2772
DELISTED
Century Bancorp Inc/Mass
CNBKA
$11.9M ﹤0.01%
132,704
+4,041
+3% +$353K
NERV icon
2773
Minerva Neurosciences
NERV
$199M
$11.9M ﹤0.01%
209,625
-2,909
-1% -$128K
CX icon
2774
Cemex
CX
$16.3B
$11.9M ﹤0.01%
3,145,205
-301,652
-9% -$1.15M
EBTC
2775
DELISTED
Enterprise Bancorp
EBTC
$11.8M ﹤0.01%
349,827
+1,498
+0.4% +$46.4K
109 110
111
112 113

Similar funds

Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
VRS
Virginia Retirement Systems Richmond, Virginia $16.8B AUM 25.91% 1-Year Est. Return
FAF
Första AP-fonden Stockholm, Sweden $16.8B AUM 29.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.